Atlas Trials

A Phase I Study of CD19 Specific T Cells in CD19 Positive Malignancy

Clinical trial NCT01493453 · TERMINATED

Trial details

NCT number
NCT01493453
Sponsor
The Christie NHS Foundation Trust
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
CD19 Positive Non-Hodgkin Lymphoma
Start date
2008-03-01
Primary completion
2014-12-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.